Acta Med. 2012, 55: 180-185

https://doi.org/10.14712/18059694.2015.43

Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis

Vít Řeháčeka, Milan Bláhab, Hana Jiroušováa, Jitka Černohorskáa, Petr Papoušeka

aCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Czech Republic: Transfusion Department
b4th Department of Medicine, Hematology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové

Received June 28, 2012
Accepted October 29, 2012

Crossref Cited-by Linking

  • Sileno Sean M., Koop Andree H., Palmer William C.: 20-Year-Old Man With Elevated Liver Tests. Mayo Clinic Proceedings 2022, 97, 790. <https://doi.org/10.1016/j.mayocp.2021.09.024>
  • Hardin C. Corey, Olynyk John K., Ramm Grant A.: Hemochromatosis. N Engl J Med 2022, 387, 2159. <https://doi.org/10.1056/NEJMra2119758>
  • Prabhu Anil, Cargill Tamsin, Roberts Nia, Ryan John D.: Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis. Hepatology 2020, 72, 1469. <https://doi.org/10.1002/hep.31405>
  • Sanderson Frederick, Cauchois Raphaël, Berda‐Haddad Yael, Poullin Pascale: Automated red blood cell depletion: Results from a validation trial of the Fenwal Amicus new red blood cell depletion program. J of Clinical Apheresis 2020, 35, 335. <https://doi.org/10.1002/jca.21802>
  • Ong Sim Y., Nicoll Amanda J., Delatycki Martin B.: How should hyperferritinaemia be investigated and managed?. European Journal of Internal Medicine 2016, 33, 21. <https://doi.org/10.1016/j.ejim.2016.05.014>
Crossref Cited-by Linking logo